SMNDC1 Activators
Chemical activators of SMNDC1 utilize diverse cellular mechanisms to modulate the protein's activity through phosphorylation. Forskolin engages in this process by stimulating adenylate cyclase, which increases intracellular cAMP levels. The surge in cAMP activates Protein Kinase A (PKA), a pivotal enzyme in phosphorylation signaling, which can directly target SMNDC1 for phosphorylation, altering its activity. Ionomycin operates by a distinct mechanism, acting as a calcium ionophore that raises intracellular calcium concentrations. This elevation in calcium ions can activate a variety of calcium-dependent kinases, such as calmodulin-dependent protein kinases, which are capable of phosphorylating SMNDC1. Phorbol 12-myristate 13-acetate (PMA), another chemical activator, specifically targets Protein Kinase C (PKC), promoting the phosphorylation of serine and threonine residues on proteins, including SMNDC1.
Additional chemicals like Okadaic acid and Calyculin A inhibit protein phosphatases such as PP1 and PP2A, preventing the dephosphorylation of proteins within the cell. This inhibition contributes to a heightened phosphorylation state of proteins, including SMNDC1, thus enhancing its activation state. Similarly, Anisomycin activates stress-activated protein kinases, which may phosphorylate and therefore activate SMNDC1. Epidermal Growth Factor (EGF) initiates a cascade of events through the MAPK/ERK pathway, potentially culminating in SMNDC1 activation. Dibutyryl-cAMP (db-cAMP), a cAMP analog, activates PKA, which can target SMNDC1. A23187, like ionomycin, raises intracellular calcium levels, which may activate SMNDC1 through calcium-dependent kinases. Staurosporine and Bisindolylmaleimide I (BIM I) are kinase inhibitors that, under certain conditions, can lead to the activation of alternative kinases that may phosphorylate SMNDC1. Lastly, Thapsigargin disrupts calcium homeostasis by inhibiting the SERCA pump, potentially resulting in the activation of calcium-dependent signaling pathways and subsequent phosphorylation of SMNDC1.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin acts as a calcium ionophore, elevating intracellular calcium levels, which can activate calmodulin-dependent protein kinases (CaMKs). These kinases can phosphorylate target proteins, which may include SMNDC1, leading to its functional activation within its associated pathways. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C (PKC) which is involved in the phosphorylation of serine and threonine residues on various proteins. This activation pathway can lead to the phosphorylation and subsequent activation of SMNDC1. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
Okadaic acid is a potent inhibitor of protein phosphatases 1 (PP1) and 2A (PP2A), which leads to the increased phosphorylation state of cellular proteins by preventing their dephosphorylation. This can result in the enhanced phosphorylation and activation of SMNDC1. | ||||||
Calyculin A | 101932-71-2 | sc-24000 sc-24000A | 10 µg 100 µg | $163.00 $800.00 | 59 | |
Like okadaic acid, Calyculin A inhibits PP1 and PP2A, leading to increased phosphorylation levels of proteins within the cell. Through this mechanism, Calyculin A can contribute to the activation of SMNDC1. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is known to activate stress-activated protein kinases such as JNK (c-Jun N-terminal kinase) and p38 MAP kinase, which can phosphorylate a range of substrates, potentially including SMNDC1, thereby activating it. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
db-cAMP is a cell-permeable cAMP analog which activates PKA. PKA then phosphorylates various proteins within the cell, which may lead to the activation of SMNDC1 through phosphorylation. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is a calcium ionophore that raises intracellular calcium concentrations, possibly resulting in the activation of calcium-dependent protein kinases that could phosphorylate and activate SMNDC1. | ||||||
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent, non-selective inhibitor of protein kinases. At low concentrations, it can paradoxically activate certain kinases before inhibiting them, which could lead to the activation of SMNDC1 through phosphorylation. | ||||||
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $105.00 $242.00 | 36 | |
BIM I is a specific inhibitor of PKC, but through its selective inhibition, it can lead to compensatory actions within the cell that may result in the activation of alternative pathways or kinases that could phosphorylate and activate SMNDC1. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin is a SERCA pump inhibitor that leads to increased cytosolic calcium levels, which can activate calcium-dependent signaling pathways, potentially resulting in the phosphorylation and activation of SMNDC1. | ||||||